Commission Regulation (EEC) No 2061/89 of 7 July 1989 concerning the classification of certain goods in the combined nomenclature
Modified by
  • Commission Regulation (EC) No 936/1999of 27 April 1999amending or repealing certain regulations on the classification of goods in the Combined Nomenclature, 31999R0936, May 5, 1999
  • Commission Regulation (EC) No 1966/2005of 1 December 2005amending Regulation (EEC) No 2061/89 concerning the classification of certain goods in the Combined Nomenclature, 32005R1966, December 2, 2005
  • Commission Implementing Regulation (EU) No 441/2013of 7 May 2013amending or repealing certain regulations on the classification of goods in the Combined Nomenclature, 32013R0441, May 15, 2013
Commission Regulation (EEC) No 2061/89of 7 July 1989concerning the classification of certain goods in the combined nomenclature
Article 1The goods described in column 1 of the annexed table are now classified within the combined nomenclature under the appropriate CN codes indicated in column 2 of the said table.
Article 2This Regulation shall enter into force on the 21st day following its publication in the Official Journal of the European Communities.
This Regulation shall be binding in its entirety and directly applicable in all Member States.ANNEX
Description of the goodsClassification (CN code)Reasons
(1)(2)(3)
1.Preparation in the form of tablets put up in packings for retail sale with instructions on dosage and composition to counter deficiency resulting from food lacking in proteins.Composition per 100 g of the preparation:L-histidine: 4,2 gL-isoleucine: 4,2 gL-leucine: 4,2 gL-lysine: 4,2 gL-methionine: 4,2 gL-phenylalanine: 4,2 gL-threonine: 4,2 gL-tryptophan: 4,2 gL-valine: 4,2 gL-cystine: 2,8 gL-glycine: 2,8 gL-cysteïn: 2,8 gL-tyrosine: 2,8 gL-taurine: 2,8 gL-arginine: 2,8 gL-ornithine: 2,8 gL-glutamine: 2,8 gL-alanine: 1,4 gL-aspartic acid: 1,4 gL-glutamic acid: 1,4 gL-citruline: 1,4 gL-serine: 1,4 gL-proline: 1,4 gL-glutathion: 1,4 gL-carnitine: 1,4 gCellulose, stearic acid, magnesium stearate, silicon dioxide and food glaze containing protein: ad 100 g21069092Classfication is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and the texts of CN codes 2106, 210690 and 21069092.The products is a food supplement (see also HS Explanatory Note to heading 21.06)
2.Preparation in the form of tablets put up in packings for retail sale with 0instructions on dosage and composition to counter, in particular, deficiency resulting from the growth of children.Composition per 100 g of the preparation:glycine: 36,2 gL-ornithine: 27,2 gL-tryptophan: 9,1 gNiacinamide: 2,2 gVitamin B6: 0,8 g;Cellulose, stearic acid, magnesium stearate, silicon dioxide, and food glaze containing protein: ad 100 g21069092Classification is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and the texts of CN codes 2106, 210690 and 21069092.The product is a food supplement (see also HS Explanatory Note to heading 21.06)
3.Preparation in the form of tablets put up in packings for retail sale with instructions on dosage and composition to counter deficiency resulting from the menstruation of women.Composition per 100 g of the preparation:Oil of evening primrose: 11,4 gVitamin B6: 6,8 gMagnesium oxide: 5,7 gCalcium carbonate: 2,9 gHerbal mixture: 2,4 gPotassium gluconate: 2,3 gFolic acid: 0,009 gCellulose, stearic acid, magnesium stearate, silicon dioxide and food glaze containing protein: ad 100 g21069092Classification is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and the texts of CN codes 2106, 210690 and 21069092.The product is a food supplement (see also HS code Explanatory Note to heading 21.06)
4.Preparation in the form of tablets put up in packings for retail sale with instructions on dosage and composition, to ensure a balance of substances contained in hair.Each tablet of approximately 2g contains:Biotin: 500 μgL-Cysteine: 150 mgCholine bitartrate: 125 mgInositol: 62,5 mgVitamin B12: 12,5 μgFolic acid: 400 μgAscorbic acid: 150 mgManganese gluconate: 5 mgPara aminobenzoic acid: 37,5 mgNiacinamide: 15 mgPanothenic acid: 50 mgVitamin B6: 37,5 mgZinc gluconate: 15 mgFerrous gluconate: 10 mgIodine: 75 μgCopper gluconate: 1 mgMillet extract: 200 mgIn a base containing:Beta carotene, aloe vera, amino acids, cellulose, stearic acid and food glaze containing protein21069092Classification is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and the texts of CN codes 2106, 210690 and 21069092.The product is a food supplement (see also HS Explanatory Note to heading 21.06)
5.Preparation in the form of tablets put up in packages for retail sale with instructions on dosage and composition, to counter deficiency in vitamin C.Each tablet weighing 750 mg contains:Ascorbic acid: 500 mgRose hip powder, cellulose, vegetable stearine, botanical oil solids, magnesium stearate, silicon dioxide and food glaze containing protein: 250 mg.30045000Classification is determined by General Rules 1 and 6 for the interpretation of the combined nomenclature, Additional Note 1 to Chapter 30 and by the wording of the CN codes 3004, 300450 and 30045000.See also the Combined Nomenclature Explanatory Notes to Chapter 30 (General).As regards the recommended daily allowance (RDA) for vitamin C (60 mg), each tablet clearly contains a much higher amount of vitamin C (500 mg).All conditions of Additional Note 1 to Chapter 30 are therefore met and the product is to be classified as a medicament of Heading 3004.
6.Injectable preparation, sterile, pyrogen-free, consisting of purified collagen dispersed in a phosphate physiological saline buffered solution, whether or not containing lidocaine (INN), put up for retail sale30049000Classficiation is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and the texts of CN codes 3004, 300490 and 30049000.This product is used in the treatment of atrophy due to disease, trauma or other disorders of the conjunctive tissue
Article 1The goods described in column 1 of the annexed table are now classified within the combined nomenclature under the appropriate CN codes indicated in column 2 of the said table.
Article 2This Regulation shall enter into force on the 21st day following its publication in the Official Journal of the European Communities.
This Regulation shall be binding in its entirety and directly applicable in all Member States.ANNEX
Description of the goodsClassification (CN code)Reasons
(1)(2)(3)
1.Preparation in the form of tablets put up in packings for retail sale with instructions on dosage and composition to counter deficiency resulting from food lacking in proteins.Composition per 100 g of the preparation:L-histidine: 4,2 gL-isoleucine: 4,2 gL-leucine: 4,2 gL-lysine: 4,2 gL-methionine: 4,2 gL-phenylalanine: 4,2 gL-threonine: 4,2 gL-tryptophan: 4,2 gL-valine: 4,2 gL-cystine: 2,8 gL-glycine: 2,8 gL-cysteïn: 2,8 gL-tyrosine: 2,8 gL-taurine: 2,8 gL-arginine: 2,8 gL-ornithine: 2,8 gL-glutamine: 2,8 gL-alanine: 1,4 gL-aspartic acid: 1,4 gL-glutamic acid: 1,4 gL-citruline: 1,4 gL-serine: 1,4 gL-proline: 1,4 gL-glutathion: 1,4 gL-carnitine: 1,4 gCellulose, stearic acid, magnesium stearate, silicon dioxide and food glaze containing protein: ad 100 g21069092Classfication is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and the texts of CN codes 2106, 210690 and 21069092.The products is a food supplement (see also HS Explanatory Note to heading 21.06)
2.Preparation in the form of tablets put up in packings for retail sale with 0instructions on dosage and composition to counter, in particular, deficiency resulting from the growth of children.Composition per 100 g of the preparation:glycine: 36,2 gL-ornithine: 27,2 gL-tryptophan: 9,1 gNiacinamide: 2,2 gVitamin B6: 0,8 g;Cellulose, stearic acid, magnesium stearate, silicon dioxide, and food glaze containing protein: ad 100 g21069092Classification is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and the texts of CN codes 2106, 210690 and 21069092.The product is a food supplement (see also HS Explanatory Note to heading 21.06)
3.Preparation in the form of tablets put up in packings for retail sale with instructions on dosage and composition to counter deficiency resulting from the menstruation of women.Composition per 100 g of the preparation:Oil of evening primrose: 11,4 gVitamin B6: 6,8 gMagnesium oxide: 5,7 gCalcium carbonate: 2,9 gHerbal mixture: 2,4 gPotassium gluconate: 2,3 gFolic acid: 0,009 gCellulose, stearic acid, magnesium stearate, silicon dioxide and food glaze containing protein: ad 100 g21069092Classification is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and the texts of CN codes 2106, 210690 and 21069092.The product is a food supplement (see also HS code Explanatory Note to heading 21.06)
4.Preparation in the form of tablets put up in packings for retail sale with instructions on dosage and composition, to ensure a balance of substances contained in hair.Each tablet of approximately 2g contains:Biotin: 500 μgL-Cysteine: 150 mgCholine bitartrate: 125 mgInositol: 62,5 mgVitamin B12: 12,5 μgFolic acid: 400 μgAscorbic acid: 150 mgManganese gluconate: 5 mgPara aminobenzoic acid: 37,5 mgNiacinamide: 15 mgPanothenic acid: 50 mgVitamin B6: 37,5 mgZinc gluconate: 15 mgFerrous gluconate: 10 mgIodine: 75 μgCopper gluconate: 1 mgMillet extract: 200 mgIn a base containing:Beta carotene, aloe vera, amino acids, cellulose, stearic acid and food glaze containing protein21069092Classification is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and the texts of CN codes 2106, 210690 and 21069092.The product is a food supplement (see also HS Explanatory Note to heading 21.06)
5.Preparation in the form of tablets put up in packages for retail sale with instructions on dosage and composition, to counter deficiency in vitamin C.Each tablet weighing 750 mg contains:Ascorbic acid: 500 mgRose hip powder, cellulose, vegetable stearine, botanical oil solids, magnesium stearate, silicon dioxide and food glaze containing protein: 250 mg.30045000Classification is determined by General Rules 1 and 6 for the interpretation of the combined nomenclature, Additional Note 1 to Chapter 30 and by the wording of the CN codes 3004, 300450 and 30045000.See also the Combined Nomenclature Explanatory Notes to Chapter 30 (General).As regards the recommended daily allowance (RDA) for vitamin C (60 mg), each tablet clearly contains a much higher amount of vitamin C (500 mg).All conditions of Additional Note 1 to Chapter 30 are therefore met and the product is to be classified as a medicament of Heading 3004.
6.Injectable preparation, sterile, pyrogen-free, consisting of purified collagen dispersed in a phosphate physiological saline buffered solution, whether or not containing lidocaine (INN), put up for retail sale30049000Classficiation is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and the texts of CN codes 3004, 300490 and 30049000.This product is used in the treatment of atrophy due to disease, trauma or other disorders of the conjunctive tissue